In an unprecedented move American Green (OTCPINK:ERBB) announced on August 3, it had successfully purchased the small California town of Nipton, which plans to transform into a production “hub.”
As part of their first efforts, once they begin production in the town, American Green plans to focus on the “bottling if fresh-CBD infused water” that the company plans to distribute in the state of California.
“This acquisition allows us to channel the myriad interests in cannabis production and consumption for an immediate positive impact to this community’s members and to cannabis consumers across the country,” chairman and president of American Green, David Gwyther said in a press release.
American Green seeks to revitalize the small town into “an effective hub for the production of various cannabis-based products” with the possibility of a fully-licensed cultivation including consumption. The company also hopes to add various commercial and recreational attractions like CBD and mineral baths and cannabis-product retail outposts.
The price wasn’t disclosed, however, current owner Roxanne Lang said was listed at $5 million when it was put up for sale last year.

Analyst Take

Alan Brochstein, a cannabis financial analyst with 420 Investor, wrote it was unclear how this company was actually affording this purchase since his review of American Green’s financial results, showed “a company in distress.”
As part of the company’s financial disclosure for the third quarter of 2017, American green revealed their current cash flow held $191,287. The company is also facing liabilities of over $8.5 million.
“American Green, with a market cap of $22mm but no net assets and regular operating losses, is on a serial dilution treadmill from which it is unlikely to escape anytime soon, even before taking on the additional expenses required for the Nipton project,” Brochstein wrote.
The past five trading days for American Green have been tumultuous as it saw a massive 109.09 percent increase overall, leading it to a year-high of $0.004. However, on Tuesday the company saw a 37.84 percent drop off, which put their stock back down priced at $0.002. As of market closure on August 8, over a year-to-date basis, ERBB has seen a 0 percent increase.
“American Green has been an incredible disappointment for investors since inception, as the company has failed to produce material revenue but has dramatically increased its share-count due to the issuance of stock to holders of its convertible debt,” Brochstein added.
Don’t forget to follow us @INN_LifeScience and @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less